Detection of Suspected Paper Mill Publications in Cancer Research Using Machine Learning
January 30, 2026
Brand Name :
Condylox
Synonyms :
podofilox
Class :
Keratolytic Agents
Dosage Forms & Strengths
Solution or gel
0.5%
Safety & efficacy not established
Adverse drug reactions
Frequency Defined
>10%
Erosion (44-48%)
Inflammation (63%)
Bleeding (22%)
Burning (63%)
Pruritus (44-48%)
Pain (44-48%)
1-10%
Dizziness
Stinging (7%)
Erythema (5%)
Hematuria
Headache (6-9%)
Insomnia
Pregnancy warnings:
Pregnancy: C
Lactation:
Excreted into human milk is unknown
Pregnancy Categories:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: podofilox
Why do we use podofilox?
podofilox is an Keratolytic Agents used to treat Anogenital Warts.